524804:BOM
Aurobindo Pharma Ltd
₹1,433.35
arrow_upward
+0.28%(+4.00) 1D
Jun 3, 3:30:00 PM GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 524804...
Open
₹1,429.40
High
₹1,457.90
Low
₹1,420.80
Mkt. cap
825.67B
Avg. vol.
48.71K
Volume
39.29K
Dividend
0.28%
Quarterly dividend
₹1.00
Ex-dividend date
Aug 8, 2025
P/E ratio
23.75
52-wk high
₹1,550.00
52-wk low
₹1,017.00
EPS
₹60.34
Shares outstanding
585.90M
No. of employees
28K
Open
₹1,429.40
High
₹1,457.90
Low
₹1,420.80
Mkt. cap
825.67B
Avg. vol.
48.71K
Volume
39.29K
Dividend
0.28%
Quarterly dividend
₹1.00
Ex-dividend date
Aug 8, 2025
P/E ratio
23.75
52-wk high
₹1,550.00
52-wk low
₹1,017.00
EPS
₹60.34
Shares outstanding
585.90M
No. of employees
28K
News stories
From sources across the web
CNBC TV18
·
1 hour ago
Stocks to Watch for June 4: Aurobindo Pharma, Indigo, NBCC and more
Profile
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
About Aurobindo Pharma Ltd
CEO-
Employees27.7K
Founded1986
HeadquartersHyderabad, Andhra Pradesh, India
SectorPharmaceutical industry
Websiteaurobindo.com
AI content may include mistakes. Learn more